The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Open accessAbstract
The Transforming Growth Factor-beta (TGF-β) family plays relevant roles in the regulation of different cellular processes that are essential for tissue and organ homeostasis. In the case of the liver, TGF-β signaling participates in different stages of disease progression, from initial liver injury toward fibrosis, cirrhosis and cancer. When a chronic injury takes place, mobilization of lymphocytes and other inflammatory cells occur, thus setting the stage for persistence of an inflammatory response. Macrophages produce profibrotic mediators, among them, TGF-β, which is responsible for activation -transdifferentiation- of quiescent hepatic stellate cells (HSC) to a myofibroblast (MFB) phenotype. MFBs are the principal source of extracellular matrix protein (ECM) accumulation and prominent mediators of fibrogenesis. TGF-β also mediates an epithelial-mesenchymal transition (EMT) process in hepatocytes that may contribute, directly or indirectly, to increase the MFB population. In hepatocarcinogenesis, TGF-β plays a dual role, behaving as a suppressor factor at early stages, but contributing to later tumor progression, once cells escape from its cytostatic effects. As part of its potential pro-tumorigenic actions, TGF-β induces EMT in liver tumor cells, which increases its pro-migratory and invasive potential. In parallel, TGF-β also induces changes in tumor cell plasticity, conferring properties of a migratory tumor initiating cell (TIC). The main aim of this review is to shed light about the pleiotropic actions of TGF-β that explain its effects on the different liver cell populations. The cross-talk with other signaling pathways that contribute to TGF-β effects, in particular the Epidermal Growth Factor Receptor (EGFR), will be presented. Finally, we will discuss the rationale for targeting the TGF-β pathway in liver pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Valdés, F., Murillo, M. M., Valverde, Á. M., Herrera, B. M., Sánchez, A., Benito, M., Fernández, M., & Fabregat, I. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.08.015 · Cited by 59
Self-citationCao, Y., Agarwal, R., Dituri, F., Lupo, L., Trerotoli, P., Mancarella, S., Winter, P., & Giannelli, G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.44 · Cited by 54
Sancho, P., & Fabregat, I. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.007 · Cited by 53
Self-citationTGF-β signaling pathway as a pharmacological target in liver diseases
Zhang, S., Sun, W., Wu, J., & Wei, W. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.005 · Cited by 51
Dysregulation of redox pathways in liver fibrosis
Torok, N. J. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00050.2016 · Cited by 47
Rani, B., Malfettone, A., Dituri, F., Soukupová, J., Lupo, L., Mancarella, S., Fabregat, I., & Giannelli, G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0384-5 · Cited by 47
Self-citationTransforming growth factor‐β in liver cancer stem cells and regeneration
Rao, S., Zaidi, S., Banerjee, J., Jogunoori, W. S., Sebastian, R., Mishra, B., Nguyen, B.-N. H., Wu, R., White, J. C., Deng, C., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1062 · Cited by 46
Apoptotic Response to TGF-$beta; in Fetal Hepatocytes Depends upon Their State of Differentiation
Sánchez, A. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4624 · Cited by 45
Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model
Hammad, S., Cavalcanti, E., Werle, J., Caruso, M. L., Dropmann, A., Ignazzi, A., Ebert, M. P. A., Dooley, S., & Giannelli, G. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2231-y · Cited by 44
Abhilash, P. A., Harikrishnan, R., & Indira, M. (2011) · Free Radical Research · doi:10.3109/10715762.2011.647691 · Cited by 41
Targeting Signalling Pathways in Hepatocellular Carcinoma
Cokan, K. B., & Rozman, D. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161006160005 · Cited by 40
Hanafy, N. A. N., Quarta, A., Corato, R. D., Dini, L., Nobile, C., Tasco, V., Carallo, S., Cascione, M., Malfettone, A., Soukupová, J., et al. (2017) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-017-5930-7 · Cited by 40
Self-citationRole of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
Rani, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i15.4128 · Cited by 37
Dituri, F., Mazzocca, A., Fernando, J., Papappicco, P., Fabregat, I., Santis, F. D., Paradiso, A., Sabbà, C., & Giannelli, G. (2013) · PLoS ONE · doi:10.1371/annotation/c943a596-3965-4a5b-a27c-55c16685ea32 · Cited by 37
Self-citationImmune Control in Hepatocellular Carcinoma Development and Progression: Role of Stromal Cells
Sprinzl, M. F., & Galle, P. R. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1394138 · Cited by 36
Polymeric Nano-Micelles as Novel Cargo-Carriers for LY2157299 Liver Cancer Cells Delivery
Hanafy, N. A. N., Quarta, A., Ferraro, M. M., Dini, L., Nobile, C., Giorgi, M. L. D., Carallo, S., Citti, C., Gaballo, A., Cannazza, G., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030748 · Cited by 36
Cross-Talk Between TGF-β and NADPH Oxidases During Liver Fibrosis and Hepatocarcinogenesis
Crosas‐Molist, E., Bertrán, E., & Fabregat, I. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151029112126 · Cited by 35
Self-citationSoukupová, J., Bertrán, E., Peñuelas‐Haro, I., Urdiroz-Urricelqui, U., Borgman, M., Kohlhof, H., & Fabregat, I. (2017) · Oncotarget · doi:10.18632/oncotarget.22775 · Cited by 33
Self-citationUp-Regulation of RACK1 by TGF-β1 Promotes Hepatic Fibrosis in Mice
Jia, D., Duan, F., Peng, P., Sun, L., Liu, X., Wang, L., Wu, W., Ruan, Y., & Gu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060115 · Cited by 31
Wang, L., Clutter, S. D., Benincosa, J., Fortney, J. E., & Gibson, L. F. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0354 · Cited by 28
Moreno‐Càceres, J., Mainez, J., Mayoral, R., Martín‐Sanz, P., Egea, G., & Fabregat, I. (2016) · FEBS Journal · doi:10.1111/febs.13669 · Cited by 27
Self-citationEffect of Rho A on transforming growth factor β1‐induced rat hepatic stellate cell migration
Li, L., Wang, J., Yang, C., & Jiang, W. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02809.x · Cited by 25
Koslowski, R., Seidel, D., Kuhlisch, E., & Knoch, K.-P. (2003) · Experimental and Toxicologic Pathology · doi:10.1078/0940-2993-00323 · Cited by 23
del Castillo, G., Alvarez, A. M., Carmona‐Cuenca, I., Fernández, M., Sánchez, A., & Fabregat, I. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21370 · Cited by 23
Self-citationCD14‐positive hepatic monocytes/macrophages increase in hereditary hemochromatosis
Leicester, K. L., Olynyk, J. K., Brunt, E. M., Britton, R. S., & Bacon, B. R. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0943.x · Cited by 19
RACK1-mediated translation control promotes liver fibrogenesis
Liu, M., Peng, P., Wang, J., Wang, L., Duan, F., Jia, D., Ruan, Y., & Gu, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.040 · Cited by 17
Cited by
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
Liver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307
Cancer nanotechnology: current status and perspectives
Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 266
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
Mohammed, S., Thadathil, N., Selvarani, R., Nicklas, E. H., Wang, D., Miller, B. F., Richardson, A., & Deepa, S. S. (2021) · Aging Cell · doi:10.1111/acel.13512 · Cited by 192
Danger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
Metadata
- Authors
- Fabregat, I., & Caballero-Díaz, D.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2018-09-10
- Volume
- 8
- Pages
- 357-357
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2890778790
- Cited by
- 351
- References
- 226
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.